ViewLinc 3.5 monitors larger pharma facilities

Published: 23-Jul-2010
Manufacturing

For applications where product quality or patient safety is a concern

The viewLinc 3.5 from Canadian firm Veriteq, now part of the Controlled Environments division of Vaisala of Finland, is aimed at pharmaceutical processors seeking continuous monitoring systems specifically geared to larger enterprises.

This continuous monitoring system can be used in FDA regulated, GxP compliant environments, and all applications where product quality or patient safety is a concern. It provides continuous records, 24/7 alarming, and automated reporting and is easily deployed for monitoring temperature, relative humidity, CO2, differential pressure, level, door switches, and more.

ViewLinc 3.5 enhancements include:

  • Faster updates for 1000+ sensors
  • Faster updates to display data and events
  • Advanced alarm scheduling
  • Zone security for customised access and viewing
  • Easy installation on existing networks
  • Web-based access for multiple facilities worldwide

This latest version of viewLinc continues to ensure gap-free data recording with triple redundancy — point-of-measurement, host server, and automatic data transfers.

Highly secure and audit-trail capable, it meets compliance requirements for 21 CFR Part 11, CBER, The Joint Commission, AATB, AABB, and other life science and technology regulatory and accreditation bodies.

  • Companies:
  • Vaisala Ltd
See more

You may also like

Manufacturing

GMP monitoring system brings peace of mind to drug manufacturer

Read more
The quality of manufactured or processed products in cleanroom facilities is ensured by current good manufacturing practices (cGMPs) that specify stringent environmental monitoring requirements

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be complicated. Here, the tablet experts Natoli explain how to develop tabletability, compactibility, and compressibility profiles
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

GMP monitoring system brings peace of mind to drug manufacturer

The quality of manufactured or processed products in cleanroom facilities is ensured by current good manufacturing practices (cGMPs) that specify stringent environmental monitoring requirements
Manufacturing

Developing and manufacturing accurate and reproducible APIs

The measurement of the refractive index (RI) is employed by a wide variety of industries to determine the level of dissolved solids in liquids. This is an important but relatively new function in the development and manufacture of active pharmaceutical ingredients (APIs) at laboratory, pilot and industrial scale in pharmaceutical manufacturing and processing facilities
Design & Build

Vaisala makes segment structure changes to its business

Will integrate Building Automation and High Technology into Targeted Industrial Applications
Manufacturing

Wired for Quality

There are many data recording options when monitoring critical environments. Ken Appel, manager Regulated Markets, Veriteq, highlights their pros and cons
Manufacturing

Vaisala to hold webinars about humidity measurement

Five part series aimed at pharma, biotech, medical device and other life science companies
Design & Build

Vaisala probes monitor humidity in critical environments

LIVE FROM TOTAL PROCESSING & PACKAGING
Manufacturing

WuXi AppTec peptide facility receives PMDA approval

The company's Changzhou oligonucleotide API manufacturing site was approved by Japan's Pharmaceuticals and Medical Devices Agency
Subscribe now